WO2020218877A1 - Diagnostic device and method for operating diagnostic device - Google Patents

Diagnostic device and method for operating diagnostic device Download PDF

Info

Publication number
WO2020218877A1
WO2020218877A1 PCT/KR2020/005442 KR2020005442W WO2020218877A1 WO 2020218877 A1 WO2020218877 A1 WO 2020218877A1 KR 2020005442 W KR2020005442 W KR 2020005442W WO 2020218877 A1 WO2020218877 A1 WO 2020218877A1
Authority
WO
WIPO (PCT)
Prior art keywords
magnet
reaction well
reaction
diagnostic device
buffer solution
Prior art date
Application number
PCT/KR2020/005442
Other languages
French (fr)
Korean (ko)
Inventor
김희준
송규정
육종석
김성준
Original Assignee
프리시젼바이오 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020190048743A external-priority patent/KR102188470B1/en
Priority claimed from KR1020190048735A external-priority patent/KR102182254B1/en
Application filed by 프리시젼바이오 주식회사 filed Critical 프리시젼바이오 주식회사
Publication of WO2020218877A1 publication Critical patent/WO2020218877A1/en

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00Other mixers; Mixing plants; Combinations of mixers
    • B01F33/45Magnetic mixers; Mixers with magnetically driven stirrers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor

Definitions

  • the present invention relates to a method of driving a diagnostic device and a diagnostic device. More specifically, the present invention relates to a driving method and a diagnostic device for performing diagnosis by reacting a conjugate and a reactant.
  • the in vitro diagnostic industry is a field in which various diseases such as diabetes, cholesterol, cancer, etc. can be checked with a drop of blood, urine, etc., and in vitro diagnostic devices that enable users to check various diseases at home or while carrying are being developed. .
  • An object of the present invention is to provide a method of driving a diagnostic device and a diagnostic device capable of inducing an effective reaction between a conjugate and a reactant.
  • the present invention includes the steps of introducing a sample containing a reactant into a reaction well; Injecting a buffer solution into the reaction well; Forming a reaction product by reacting the conjugates in the reaction well and the reactant; Removing the buffer solution in the reaction well; And it provides a method of driving a diagnostic device comprising the step of measuring the reaction result.
  • Forming the reaction product may include rotating the second magnet in the reaction well.
  • Rotating the second magnet may include rotating the first magnet outside the reaction well to rotate the second magnet.
  • the rotation of the second magnet may include rotation of the second magnet so that the third magnet in the reaction well separates from the second magnet.
  • the step of forming the reaction product may include reacting the first conjugate connected to the third magnet and the second conjugate connected to the light-emitting body with the reactant.
  • the step of removing the buffer solution in the reaction well may include attaching the third magnet to the second magnet in the reaction well, and not moving the reaction product together with the buffer solution.
  • the step of removing the buffer solution in the reaction well may include removing the light-emitting body and the second assembly that are not connected to the third magnet together with the buffer solution.
  • the step of measuring the reaction result may include uniformly distributing the light emitter by stirring the buffer solution in the reaction well.
  • the present invention is a reaction well comprising an inner space; A first magnet other than the reaction well; A second magnet provided in the reaction well and spaced apart from the first magnet by the reaction well; A third magnet in the reaction well; A first bonding body connected to the third magnet; A light emitter in the reaction well; And a second conjugate connected to the light-emitting body.
  • the first magnet may be rotatable.
  • the second magnet may rotate according to the rotation of the first magnet.
  • the first conjugate may be bonded to the reactant, and the second conjugate may be bonded to the reactant.
  • the maximum length of the first magnet may be longer than the maximum length of the second magnet.
  • It may further include a measuring unit for measuring the light emitted in the reaction well.
  • reaction well a base; Sidewalls protruding from the edge of the upper surface of the base; And
  • It may include a second opening penetrating through the sidewall.
  • the functional group of the third magnet and the functional group of the first conjugate are bonded to each other to connect the third magnet and the first conjugate, and the functional group of the luminous material and the functional group of the second conjugate are bonded to each other to the light-emitting body and the second conjugate. Can be connected.
  • a method of driving a diagnostic device and a diagnostic device according to the present invention include stirring a buffer solution in the reaction well by rotating a magnet in the reaction well, so that the conjugate and the reactant in the reaction well can react effectively.
  • FIG. 1 is a cross-sectional view of a diagnostic device according to an embodiment of the present invention.
  • FIG. 2 is a flowchart illustrating a method of driving a diagnostic device according to an embodiment of the present invention.
  • 3A, 3B, 3C, 3D, and 3E are diagrams for explaining a method of driving a diagnostic apparatus according to an exemplary embodiment of the present invention.
  • FIG. 1 is a cross-sectional view of a reaction diagnosis apparatus according to an embodiment of the present invention.
  • the reaction induction device is a reaction well (reaction well, 110), a first magnet 120, a second magnet 130, third magnets 140, the first It may include conjugates 150, light emitters 160, second conjugates 170, and measurement unit 200.
  • the reaction well 110 may have a cylindrical shape with an empty inside.
  • the reaction well 110 may include a base 111, a sidewall 112 and an inner space 113.
  • the base 111 may have a planar circular plate shape.
  • the sidewall 112 may protrude upward from the edge of the upper surface of the base 111.
  • the inner space 113 may be defined by the base 111 and the sidewall 112.
  • the sidewall 112 may planarly surround the inner space 113.
  • the reaction well 110 may further include a first opening 114 and a second opening 115.
  • the inner space 113 of the reaction well 110 may communicate with a space outside the reaction well 110 by the first and second openings 114 and 115.
  • the first opening 114 may communicate the external space above the reaction well 110 and the internal space 113 of the reaction well 110.
  • the first opening 114 may be surrounded in a plane by an upper portion of the sidewall 112.
  • the second opening 115 may penetrate through the sidewall 112 of the reaction well 110.
  • the second opening 115 may communicate the external space on the side of the reaction well 110 and the internal space 113 of the reaction well 110.
  • the first magnet 120 may be disposed outside the reaction well 110.
  • the first magnet 120 may be disposed under the base 111 of the reaction well 110.
  • the first magnet 120 may have a bar shape.
  • the maximum length of the first magnet 120 may be smaller than the diameter of the base 111 of the reaction well 110.
  • the second magnet 130 In the inner space 113 of the reaction well 110, the second magnet 130, the third magnets 140, the first bonding bodies 150, the luminous bodies 160, and the second bonding bodies 170 are Can be provided.
  • the second magnet 130 may be disposed on the base 111 of the reaction well 110.
  • the second magnet 130 may be spaced apart from the first magnet 120 with the base 111 of the reaction well 110 interposed therebetween.
  • the second magnet 130 may have a bar shape.
  • the maximum length of the second magnet 130 may be smaller than the maximum length of the first magnet 120.
  • the second and third magnets 130 and 140 may attract each other by magnetic force acting between the second and third magnets 130 and 140.
  • Each of the third magnets 140, the first conjugates 150, the light emitters 160, and the second conjugates 170 may include a functional group.
  • the third magnets 140 and the light emitters 160 may include a functional group by surface treatment.
  • the functional group of the first assembly 150 and the functional group of the third magnet 140 are bonded to each other, so that the first assembly 150 may be connected to the third magnet 140.
  • the functional group of the second conjugate 170 and the functional group of the light-emitting body 160 are bonded to each other, so that the second conjugate 170 may be connected to the light-emitting body 160.
  • the first magnet 120 may be rotatable under the base 111 of the reaction well 110. As the first magnet 120 rotates, the second magnet 130 may rotate.
  • the measurement unit 200 may be disposed on the reaction well 110.
  • the measurement unit 200 may measure light emitted from the reaction well 110.
  • the measurement unit 200 may include a light source, an optical sensor, and a processor.
  • the measurement unit 200 irradiates light into the reaction well 110 from a light source, obtains the light emitted from the reaction well 110 by the irradiated light by an optical sensor, and then obtained using a processor. Light can be analyzed.
  • the measurement unit 200 may include an optical sensor and a processor.
  • the measurement unit 200 may acquire light emitted from the reaction well 110 by an optical sensor and then analyze the acquired light using a processor.
  • FIG. 2 is a flowchart illustrating a method of driving a diagnostic device according to an embodiment of the present invention.
  • a step of injecting a sample into a reaction well (S100), injecting a buffer solution into the reaction well (S200), and forming a reaction result. (S300), a step of removing the buffer solution from the reaction well (S400), a washing step (S500), and a measurement step (S600) may be included.
  • 3A, 3B, 3C, 3D, and 3E are diagrams for explaining a method of driving a diagnostic apparatus according to an exemplary embodiment of the present invention.
  • a sample SA may be injected into the reaction well 110.
  • the sample SA may be introduced into the inner space 113 of the reaction well 110 through the first opening 114 of the reaction well 110.
  • the sample SA may be blood.
  • the sample SA may include reactants RM.
  • the reactant RM may be a material that reacts with the first conjugate 150 and the second conjugate 170 in the reaction well 110 and binds to the first conjugate 150 and the second conjugate 170.
  • the first conjugate 150 and the second conjugate 170 and the reactant RM may react with an antigen antibody.
  • the first conjugate 150 and the second conjugate 170 and the reactant RM may react with Streptavidin-Biotin.
  • the buffer solution BL may be injected into the reaction well 110.
  • the buffer solution BL may be injected into the inner space 113 of the reaction well 110 through the second opening 115 of the reaction well 110.
  • the second opening 115 of the reaction well 110 may be open or closed. By closing the second opening 115 of the reaction well 110, the buffer solution BL filling the inner space 113 of the reaction well 110 may not escape to the outside of the reaction well 110.
  • the sample SA may be diluted by the buffer solution BL injected into the reaction well 110.
  • the reactants RM of the sample SA may maintain their shape and properties without reacting with the buffer solution BL.
  • the reaction result RR may include a third magnet 140, a first conjugate 150, a light emitter 160, a second conjugate 170, and a reactant RM.
  • the step of forming the reaction product (S300) may include raising the temperature in the reaction well 110 and stirring the buffer solution BL in the reaction well 110.
  • a heat source may be disposed around the reaction well 110 to increase the temperature in the reaction well 110.
  • the temperature in the reaction well 110 may rise to a temperature at which the first and second conjugates 150 and 170 and the reactant RM can react.
  • Stirring the buffer solution BL in the reaction well 110 may include rotating the first magnet 120.
  • the first magnet 120 may rotate by a separate external force.
  • the first magnet 120 may be rotated by connecting a rotation motor to the first magnet 120.
  • the second magnet 130 may rotate.
  • the second magnet 130 may rotate according to a change in the magnetic field around the first magnet 120 due to the rotation of the first magnet 120.
  • the third magnets 140 may fall from the second magnet 130 by centrifugal force.
  • the buffer solution BL in the reaction well 110 may be stirred.
  • the first and second conjugates 150 and 170 and the reactant RM in the reaction well 110 Can react.
  • the first and second conjugates 150 and 170 may be connected to the reactant RM.
  • the reaction between the first and second conjugates 150 and 170 and the reactant RM, the third magnet 140, the first and second conjugates 150 and 170, the reactant RM, and the light emitter A reaction product RR including 160 may be formed.
  • the second opening 115 of the reaction well 110 is opened to allow the buffer solution BL in the reaction well 110 to be removed. It can be moved to the outside of the reaction well 110.
  • the third magnets 140 of the reaction products RR may be attached to the second magnet 130.
  • the reaction products RR react together with the buffer solution BL. It may not move outside the well 110. In other words, the reaction products RR may remain in the reaction well 110.
  • Materials other than the reaction products RR for example, the light-emitting body 160 and the second conjugate 170 that are not connected to the third magnet 140 are formed with the buffer solution BL and the reaction well 110 ) Can be moved outside. In other words, the remaining materials may be removed from the reaction well 110.
  • the cleaning step S500 is to fill the buffer solution BL in the reaction well 110 similar to that described in FIG. 3B, and agitate the buffer solution BL in the reaction well 110 similar to that described in FIG. 3C. It may include removing the buffer solution BL in the reaction well 110, similar to that described with reference to FIG. 3D.
  • the cleaning step (S500) the remaining materials (for example, the luminous body 160 and the second assembly 170 that are not connected to the third magnet 140) other than the reaction product RR are removed from the reaction well ( 110) can be removed. Accordingly, measurement of the reaction products RR can be made relatively accurately.
  • the reaction result RR may be measured.
  • Measuring the reaction result RR may include measuring the light by the luminous body 160 in the reaction well 110.
  • the light-emitting body 160 may be a phosphor.
  • the light emitter 160 may be a self light emitter.
  • the buffer solution BL may be filled in the reaction well 110, and the buffer solution BL in the reaction well 110 may be stirred similarly to the one described in FIG. 3C.
  • the measurement unit 200 may irradiate the incident light L1 into the reaction well 110, and the emission light L2 emitted from the reaction well 110 may be obtained from the measurement unit 200.
  • the luminous body 160 By analyzing the acquired light, it can be diagnosed whether the sample SA has a specific reactant RM. By removing the buffer solution from the reaction well (S400) and cleaning (S500), the luminous body 160 must be connected to the third magnet 140 to remain in the reaction well 110, so that the sample SA The luminous body 160 can remain in the reaction well 110 only when the luminous body 160 has a reactant RM that reacts with the first and second conjugates 150 and 170, and the light emitted from the luminous body 160 is measured. Can be obtained with (200).

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

The present invention provides a method for operating a diagnostic device, the method comprising the steps of: putting a sample including a reactant into a reaction well; pouring a buffer solution into the reaction well; reacting the reactant with conjugates in the reaction well to form a reaction product; removing the buffer solution from the reaction well; and measuring the reaction product.

Description

진단 장치의 구동 방법 및 진단 장치Diagnostic device driving method and diagnostic device
본 발명은 진단 장치의 구동 방법 및 진단 장치에 관한 것이다. 더욱 상세하게는, 본 발명은 접합체와 반응체를 반응시켜 진단을 수행하는 진단 장치의 구동 방법 및 진단 장치에 관한 것이다. The present invention relates to a method of driving a diagnostic device and a diagnostic device. More specifically, the present invention relates to a driving method and a diagnostic device for performing diagnosis by reacting a conjugate and a reactant.
최근의 예방 및 맞춤의학(personalized medicine) 시대에 발맞춰 체외진단 산업이 각광받고 있다. 상기 체외진단 산업은, 당뇨병, 콜레스테롤, 암 여부 등과 같은 각종 질병을 피 한 방울, 소변 등으로 확인할 수 있는 분야로서, 사용자가 집에서 또는 휴대하면서 각종 질병을 확인할 수 있는 체외진단 기기가 개발되고 있다.In keeping with the recent era of prevention and personalized medicine, the in vitro diagnostic industry is in the spotlight. The in vitro diagnostic industry is a field in which various diseases such as diabetes, cholesterol, cancer, etc. can be checked with a drop of blood, urine, etc., and in vitro diagnostic devices that enable users to check various diseases at home or while carrying are being developed. .
체외진단 기기의 개발에 있어 핵심 경쟁력은 표적물질과 반응하는 바이오 물질(항원, 항체, 유전자, 효소 등)을 개발하는 생명공학기술과 이를 측정하기 위한 기기를 개발하는 정보기술의 융합이다. 세계적인 체외진단 기업은 대부분 이와 같은 기술 융합을 통해 막대한 매출과 순이익을 창출하는 등 고부가가치의 지식기반 산업을 이끌어 가고 있다.The core competitiveness in the development of in vitro diagnostic devices is the fusion of biotechnology that develops biomaterials (antigens, antibodies, genes, enzymes, etc.) that react with target substances and information technology that develops devices to measure them. Most of the world's in vitro diagnostic companies are leading high value-added knowledge-based industries, generating enormous sales and net profits through such technology convergence.
본 발명은 접합체와 반응체의 효과적인 반응을 유도할 수 있는 진단 장치의 구동 방법 및 진단 장치를 제공하는 것을 목적으로 한다.An object of the present invention is to provide a method of driving a diagnostic device and a diagnostic device capable of inducing an effective reaction between a conjugate and a reactant.
본 발명은 반응체를 포함하는 시료를 리액션웰 내에 투입하는 단계; 상기 리액션웰 내에 버퍼액을 투입하는 단계; 상기 리액션웰 내의 접합체들과 상기 반응체가 반응하여, 반응 결과물을 형성하는 단계; 상기 리액션웰 내에서 상기 버퍼액을 제거하는 단계; 및 상기 반응 결과물을 계측하는 단계를 포함하는 진단 장치의 구동 방법을 제공한다.The present invention includes the steps of introducing a sample containing a reactant into a reaction well; Injecting a buffer solution into the reaction well; Forming a reaction product by reacting the conjugates in the reaction well and the reactant; Removing the buffer solution in the reaction well; And it provides a method of driving a diagnostic device comprising the step of measuring the reaction result.
상기 반응 결과물을 형성하는 단계는, 상기 리액션웰 내의 제2 자석이 회전하는 것을 포함할 수 있다.Forming the reaction product may include rotating the second magnet in the reaction well.
상기 제2 자석이 회전하는 것은, 상기 리액션웰 외부의 제1 자석이 회전하여 상기 제2 자석이 회전하는 것을 포함할 수 있다.Rotating the second magnet may include rotating the first magnet outside the reaction well to rotate the second magnet.
상기 제2 자석이 회전하는 것은, 상기 제2 자석이 회전하여 상기 리액션웰 내의 제3 자석이 상기 제2 자석과 떨어지는 것을 포함할 수 있다.The rotation of the second magnet may include rotation of the second magnet so that the third magnet in the reaction well separates from the second magnet.
상기 반응 결과물을 형성하는 단계는, 제3 자석과 연결된 제1 접합체 및 발광체와 연결된 제2 접합체가 상기 반응체와 반응하는 것을 포함할 수 있다.The step of forming the reaction product may include reacting the first conjugate connected to the third magnet and the second conjugate connected to the light-emitting body with the reactant.
상기 리액션웰 내에서 상기 버퍼액을 제거하는 단계는, 상기 제3 자석을 상기 리액션웰 내의 제2 자석에 붙이는 것, 및 상기 반응 결과물을 상기 버퍼액과 함께 이동시키지 않는 것을 포함할 수 있다.The step of removing the buffer solution in the reaction well may include attaching the third magnet to the second magnet in the reaction well, and not moving the reaction product together with the buffer solution.
상기 리액션웰 내에서 상기 버퍼액을 제거하는 단계는, 상기 버퍼액과 함께 상기 제3 자석과 연결되지 못한 상기 발광체 및 상기 제2 접합체를 제거하는 것을 포함할 수 있다.The step of removing the buffer solution in the reaction well may include removing the light-emitting body and the second assembly that are not connected to the third magnet together with the buffer solution.
상기 반응 결과물을 계측하는 단계는, 상기 리액션웰 내의 상기 버퍼액을 교반하여 발광체를 균일하게 분포시키는 것을 포함할 수 있다.The step of measuring the reaction result may include uniformly distributing the light emitter by stirring the buffer solution in the reaction well.
본 발명은 내부공간을 포함하는 리액션웰; 상기 리액션웰 외의 제1 자석; 상기 리액션웰 내에 제공되고, 상기 리액션웰에 의해 상기 제1 자석과 이격되는 제2 자석; 상기 리액션웰 내의 제3 자석; 상기 제3 자석과 연결되는 제1 접합체; 상기 리액션웰 내의 발광체; 및 상기 발광체와 연결되는 제2 접합체를 포함하는 진단 장치를 제공한다.The present invention is a reaction well comprising an inner space; A first magnet other than the reaction well; A second magnet provided in the reaction well and spaced apart from the first magnet by the reaction well; A third magnet in the reaction well; A first bonding body connected to the third magnet; A light emitter in the reaction well; And a second conjugate connected to the light-emitting body.
상기 제1 자석은 회전 가능할 수 있다. The first magnet may be rotatable.
상기 제2 자석은 상기 제1 자석의 회전에 따라 회전할 수 있다. The second magnet may rotate according to the rotation of the first magnet.
상기 제1 접합체는 반응체와 결합 가능하고, 상기 제2 접합체는 상기 반응체와 결합 가능할 수 있다. The first conjugate may be bonded to the reactant, and the second conjugate may be bonded to the reactant.
상기 제1 자석의 최대 길이는 상기 제2 자석의 최대 길이보다 길 수 있다. The maximum length of the first magnet may be longer than the maximum length of the second magnet.
상기 리액션웰 내에서 방출되는 광을 계측하는 계측부를 더 포함할 수 있다. It may further include a measuring unit for measuring the light emitted in the reaction well.
상기 리액션웰은, 베이스; 상기 베이스의 상면의 가장자리에서 돌출하는 측벽; 및The reaction well, a base; Sidewalls protruding from the edge of the upper surface of the base; And
상기 측벽을 관통하는 제2 개구를 포함할 수 있다. It may include a second opening penetrating through the sidewall.
상기 제3 자석의 작용기와 상기 제1 접합체의 작용기가 접합되어 상기 제3 자석 및 상기 제1 접합체가 연결되고, 상기 발광체의 작용기와 상기 제2 접합체의 작용기가 접합되어 상기 발광체 및 상기 제2 접합체가 연결될 수 있다. The functional group of the third magnet and the functional group of the first conjugate are bonded to each other to connect the third magnet and the first conjugate, and the functional group of the luminous material and the functional group of the second conjugate are bonded to each other to the light-emitting body and the second conjugate. Can be connected.
본 발명에 따른 진단 장치의 구동 방법 및 진단 장치는, 리액션웰 내의 자석을 회전시켜 리액션웰 내의 버퍼액을 교반하는 것을 포함함에 따라, 리액션웰 내의 접합체 및 반응체가 효과적으로 반응할 수 있다.A method of driving a diagnostic device and a diagnostic device according to the present invention include stirring a buffer solution in the reaction well by rotating a magnet in the reaction well, so that the conjugate and the reactant in the reaction well can react effectively.
도 1은 본 발명의 실시예에 따른 진단 장치의 단면도이다.1 is a cross-sectional view of a diagnostic device according to an embodiment of the present invention.
도 2는 본 발명의 실시예에 따른 진단 장치의 구동 방법을 설명하기 위한 순서도이다.2 is a flowchart illustrating a method of driving a diagnostic device according to an embodiment of the present invention.
도 3a, 3b, 3c, 3d 및 3e는 본 발명의 실시예에 따른 진단 장치의 구동 방법을 설명하기 위한 도면들이다.3A, 3B, 3C, 3D, and 3E are diagrams for explaining a method of driving a diagnostic apparatus according to an exemplary embodiment of the present invention.
본 발명의 이점 및 특징, 그리고 그것들을 달성하는 방법은 첨부되는 도면과 함께 상세하게 후술되어 있는 실시예를 참조하면 명확해질 것이다. 그러나 본 발명은 이하에서 개시되는 실시예에 한정되는 것이 아니라 서로 다른 다양한 형태로 구현될 수 있으며, 단지 본 실시예는 본 발명의 개시가 완전하도록 하고, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 발명의 범주를 완전하게 알려주기 위해 제공되는 것이며, 본 발명은 청구항의 범주에 의해 정의될 뿐이다. 명세서 전문에 걸쳐 동일 참조 부호는 동일 구성 요소를 지칭한다.Advantages and features of the present invention, and a method of achieving them will become apparent with reference to the embodiments described below in detail together with the accompanying drawings. However, the present invention is not limited to the embodiments disclosed below, but may be implemented in various different forms. It is provided to completely inform the scope of the invention to the possessor, and the invention is only defined by the scope of the claims. The same reference numerals refer to the same elements throughout the specification.
본 명세서에서 사용된 용어는 실시예들을 설명하기 위한 것이며 본 발명을 제한하고자 하는 것은 아니다. 본 명세서에서, 단수형은 문구에서 특별히 언급하지 않는 한 복수형도 포함한다. 명세서에서 사용되는 '포함한다(comprises)' 및/또는 '포함하는(comprising)'은 언급된 구성요소, 단계, 동작 및/또는 장치는 하나 이상의 다른 구성요소, 단계, 동작 및/또는 장치의 존재 또는 추가를 배제하지 않는다. 이하 본 발명의 실시예들에 대해 상세히 설명한다.The terms used in the present specification are for describing exemplary embodiments and are not intended to limit the present invention. In this specification, the singular form also includes the plural form unless specifically stated in the phrase. As used in the specification,'comprises' and/or'comprising' refers to the presence of one or more other components, steps, actions and/or devices, and/or the recited component, step, action and/or device. Or does not exclude additions. Hereinafter, embodiments of the present invention will be described in detail.
도 1은 본 발명의 실시예에 따른 반응 진단 장치의 단면도이다.1 is a cross-sectional view of a reaction diagnosis apparatus according to an embodiment of the present invention.
도 1을 참조하면, 본 발명의 실시예에 따른 반응 유도 장치는 리액션웰(reaction well, 110), 제1 자석(120), 제2 자석(130), 제3 자석들(140), 제1 접합체들(150), 발광체들(160), 제2 접합체들(170) 및 계측부(200)를 포함할 수 있다. Referring to Figure 1, the reaction induction device according to an embodiment of the present invention is a reaction well (reaction well, 110), a first magnet 120, a second magnet 130, third magnets 140, the first It may include conjugates 150, light emitters 160, second conjugates 170, and measurement unit 200.
리액션웰(110)은 내부가 빈 원통의 형태를 가질 수 있다. 리액션웰(110)은 베이스(111), 측벽(112) 및 내부공간(113)을 포함할 수 있다. 베이스(111)는 평면적으로 원형인 판(plate)의 형태를 가질 수 있다. 측벽(112)은 베이스(111)의 상면의 가장자리에서 위로 돌출할 수 있다. 베이스(111) 및 측벽(112)에 의해 내부공간(113)이 정의될 수 있다. 측벽(112)은 내부공간(113)을 평면적으로 둘러쌀 수 있다.The reaction well 110 may have a cylindrical shape with an empty inside. The reaction well 110 may include a base 111, a sidewall 112 and an inner space 113. The base 111 may have a planar circular plate shape. The sidewall 112 may protrude upward from the edge of the upper surface of the base 111. The inner space 113 may be defined by the base 111 and the sidewall 112. The sidewall 112 may planarly surround the inner space 113.
리액션웰(110)은 제1 개구(114) 및 제2 개구(115)를 더 포함할 수 있다. 제1 및 제2 개구들(114,115)에 의해, 리액션웰(110)의 내부공간(113)이 리액션웰(110) 외부의 공간과 연통될 수 있다. 제1 개구(114)는 리액션웰(110) 위의 외부 공간과 리액션웰(110)의 내부공간(113)을 연통시킬 수 있다. 제1 개구(114)는 측벽(112)의 상부에 의해 평면적으로 둘러싸일 수 있다. 제2 개구(115)는 리액션웰(110)의 측벽(112)을 관통할 수 있다. 제2 개구(115)는 리액션웰(110)의 측의 외부 공간과 리액션웰(110)의 내부공간(113)을 연통시킬 수 있다. The reaction well 110 may further include a first opening 114 and a second opening 115. The inner space 113 of the reaction well 110 may communicate with a space outside the reaction well 110 by the first and second openings 114 and 115. The first opening 114 may communicate the external space above the reaction well 110 and the internal space 113 of the reaction well 110. The first opening 114 may be surrounded in a plane by an upper portion of the sidewall 112. The second opening 115 may penetrate through the sidewall 112 of the reaction well 110. The second opening 115 may communicate the external space on the side of the reaction well 110 and the internal space 113 of the reaction well 110.
제1 자석(120)은 리액션웰(110)의 외부에 배치될 수 있다. 리액션웰(110)의 베이스(111) 아래에 제1 자석(120)이 배치될 수 있다. 일 예로, 제1 자석(120)은 바(bar)의 형태를 가질 수 있다. 제1 자석(120)의 최대 길이는, 리액션웰(110)의 베이스(111)의 직경보다 작을 수 있다.The first magnet 120 may be disposed outside the reaction well 110. The first magnet 120 may be disposed under the base 111 of the reaction well 110. For example, the first magnet 120 may have a bar shape. The maximum length of the first magnet 120 may be smaller than the diameter of the base 111 of the reaction well 110.
리액션웰(110)의 내부공간(113) 내에는 제2 자석(130), 제3 자석들(140), 제1 접합체들(150), 발광체들(160) 및 제2 접합체들(170)이 제공될 수 있다. 제2 자석(130)은 리액션웰(110)의 베이스(111) 상에 배치될 수 있다. 제2 자석(130)은 리액션웰(110)의 베이스(111)를 사이에 두고 제1 자석(120)과 이격될 수 있다. 제2 자석(130)은 바(bar)의 형태를 가질 수 있다. 제2 자석(130)의 최대 길이는 제1 자석(120)의 최대 길이보다 작을 수 있다. In the inner space 113 of the reaction well 110, the second magnet 130, the third magnets 140, the first bonding bodies 150, the luminous bodies 160, and the second bonding bodies 170 are Can be provided. The second magnet 130 may be disposed on the base 111 of the reaction well 110. The second magnet 130 may be spaced apart from the first magnet 120 with the base 111 of the reaction well 110 interposed therebetween. The second magnet 130 may have a bar shape. The maximum length of the second magnet 130 may be smaller than the maximum length of the first magnet 120.
제2 및 제3 자석들(130, 140) 사이에 작용하는 자기력에 의해, 제2 및 제3 자석들(130, 140)은 서로 끌어당길 수 있다. 제3 자석들(140), 제1 접합체들(150), 발광체들(160) 및 제2 접합체들(170) 각각은 작용기를 포함할 수 있다. 제3 자석들(140) 및 발광체들(160)은 표면처리에 의해 작용기를 포함할 수 있다. 제1 접합체(150)의 작용기와 제3 자석(140)의 작용기가 접합되어, 제1 접합체(150)는 제3 자석(140)과 연결될 수 있다. 제2 접합체(170)의 작용기와 발광체(160)의 작용기가 접합되어, 제2 접합체(170)는 발광체(160)와 연결될 수 있다.The second and third magnets 130 and 140 may attract each other by magnetic force acting between the second and third magnets 130 and 140. Each of the third magnets 140, the first conjugates 150, the light emitters 160, and the second conjugates 170 may include a functional group. The third magnets 140 and the light emitters 160 may include a functional group by surface treatment. The functional group of the first assembly 150 and the functional group of the third magnet 140 are bonded to each other, so that the first assembly 150 may be connected to the third magnet 140. The functional group of the second conjugate 170 and the functional group of the light-emitting body 160 are bonded to each other, so that the second conjugate 170 may be connected to the light-emitting body 160.
제1 자석(120)은 리액션웰(110)의 베이스(111) 아래에서 회전 가능할 수 있다. 제1 자석(120)의 회전에 따라, 제2 자석(130)이 회전할 수 있다. The first magnet 120 may be rotatable under the base 111 of the reaction well 110. As the first magnet 120 rotates, the second magnet 130 may rotate.
계측부(200)는 리액션웰(110) 위에 배치될 수 있다. 계측부(200)는 리액션웰(110) 내에서 방출되는 광을 계측할 수 있다. The measurement unit 200 may be disposed on the reaction well 110. The measurement unit 200 may measure light emitted from the reaction well 110.
일 예로, 계측부(200)는 광원, 광 센서 및 프로세서를 포함할 수 있다. 이 경우, 계측부(200)는 광원에서 리액션웰(110) 내로 광을 조사하고, 조사된 광에 의해 리액션웰(110) 내에서 방사되는 광을 광 센서로 획득한 후, 프로세서를 이용하여 획득된 광을 분석할 수 있다.For example, the measurement unit 200 may include a light source, an optical sensor, and a processor. In this case, the measurement unit 200 irradiates light into the reaction well 110 from a light source, obtains the light emitted from the reaction well 110 by the irradiated light by an optical sensor, and then obtained using a processor. Light can be analyzed.
다른 예로, 계측부(200)는 광 센서 및 프로세서를 포함할 수 있다. 이 경우, 계측부(200)는 리액션웰(110) 내에서 방사되는 광을 광 센서로 획득한 후, 프로세서를 이용하여 획득된 광을 분석할 수 있다.As another example, the measurement unit 200 may include an optical sensor and a processor. In this case, the measurement unit 200 may acquire light emitted from the reaction well 110 by an optical sensor and then analyze the acquired light using a processor.
도 2는 본 발명의 실시예에 따른 진단 장치의 구동 방법을 설명하기 위한 순서도이다.2 is a flowchart illustrating a method of driving a diagnostic device according to an embodiment of the present invention.
도 2를 참조하면, 본 발명의 실시예에 따른 진단 장치의 구동 방법은 시료를 리액션웰에 투입하는 단계(S100), 버퍼액을 리액션웰에 투입하는 단계(S200), 반응 결과물을 형성하는 단계(S300), 버퍼액을 리액션웰에서 제거하는 단계(S400), 세정 단계(S500) 및 계측 단계(S600)를 포함할 수 있다.Referring to FIG. 2, in the method of driving a diagnostic device according to an embodiment of the present invention, in the step of injecting a sample into a reaction well (S100), injecting a buffer solution into the reaction well (S200), and forming a reaction result. (S300), a step of removing the buffer solution from the reaction well (S400), a washing step (S500), and a measurement step (S600) may be included.
도 3a, 3b, 3c, 3d 및 3e는 본 발명의 실시예에 따른 진단 장치의 구동 방법을 설명하기 위한 도면들이다.3A, 3B, 3C, 3D, and 3E are diagrams for explaining a method of driving a diagnostic apparatus according to an exemplary embodiment of the present invention.
도 2 및 3a를 참조하면, 시료를 리액션웰에 투입하는 단계(S100)에서, 리액션웰(110) 내에 시료(SA)를 투입할 수 있다. 시료(SA)는 리액션웰(110)의 제1 개구(114)를 통해 리액션웰(110)의 내부공간(113)으로 투입될 수 있다. 일 예로, 상기 시료(SA)는 혈액일 수 있다. 상기 시료(SA)는 반응체들(RM)을 포함할 수 있다. 상기 반응체(RM)는 리액션웰(110) 내의 제1 접합체(150) 및 제2 접합체(170)와 반응하여, 제1 접합체(150) 및 제2 접합체(170)와 결합하는 물질일 수 있다. 예를 들면, 상기 제1 접합체(150) 및 제2 접합체(170)와 반응체(RM)는 항원 항체 반응을 할 수 있다. 다른 예를 들면, 상기 제1 접합체(150) 및 제2 접합체(170)와 반응체(RM)는 Streptavidin-Biotin 반응을 할 수 있다.Referring to FIGS. 2 and 3A, in step S100 of introducing a sample into the reaction well, a sample SA may be injected into the reaction well 110. The sample SA may be introduced into the inner space 113 of the reaction well 110 through the first opening 114 of the reaction well 110. For example, the sample SA may be blood. The sample SA may include reactants RM. The reactant RM may be a material that reacts with the first conjugate 150 and the second conjugate 170 in the reaction well 110 and binds to the first conjugate 150 and the second conjugate 170. . For example, the first conjugate 150 and the second conjugate 170 and the reactant RM may react with an antigen antibody. For another example, the first conjugate 150 and the second conjugate 170 and the reactant RM may react with Streptavidin-Biotin.
도 2 및 3b를 참조하면, 버퍼액을 리액션웰에 투입하는 단계(S200)에서, 버퍼액(BL)을 리액션웰(110) 내로 투입할 수 있다. 리액션웰(110)의 제2 개구(115)를 통해 버퍼액(BL)이 리액션웰(110)의 내부공간(113)으로 투입될 수 있다. 리액션웰(110)의 제2 개구(115)는 개폐가 가능할 수 있다. 리액션웰(110)의 제2 개구(115)를 폐쇄하여, 리액션웰(110)의 내부공간(113)을 채운 버퍼액(BL)이 리액션웰(110) 외부로 빠져나가지 않을 수 있다.Referring to FIGS. 2 and 3B, in the step S200 of introducing the buffer solution into the reaction well, the buffer solution BL may be injected into the reaction well 110. The buffer solution BL may be injected into the inner space 113 of the reaction well 110 through the second opening 115 of the reaction well 110. The second opening 115 of the reaction well 110 may be open or closed. By closing the second opening 115 of the reaction well 110, the buffer solution BL filling the inner space 113 of the reaction well 110 may not escape to the outside of the reaction well 110.
리액션웰(110)로 투입된 버퍼액(BL)에 의해, 시료(SA)가 희석될 수 있다. 시료(SA)가 버퍼액(BL)에 희석되는 경우, 시료(SA)의 반응체들(RM)은 버퍼액(BL)과 반응하지 않으면서 그의 형태 및 성질을 유지할 수 있다. The sample SA may be diluted by the buffer solution BL injected into the reaction well 110. When the sample SA is diluted in the buffer solution BL, the reactants RM of the sample SA may maintain their shape and properties without reacting with the buffer solution BL.
도 2 및 3c를 참조하면, 반응 결과물을 형성하는 단계(S300)에서, 제1 및 제2 접합체들(150, 170)과 반응체(RM)를 반응시켜, 반응 결과물(RR)을 형성할 수 있다. 반응 결과물(RR)은 제3 자석(140), 제1 접합체(150), 발광체(160), 제2 접합체(170) 및 반응체(RM)를 포함할 수 있다.2 and 3C, in the step of forming a reaction product (S300), the first and second conjugates 150 and 170 and the reactant RM are reacted to form a reaction product RR. have. The reaction result RR may include a third magnet 140, a first conjugate 150, a light emitter 160, a second conjugate 170, and a reactant RM.
반응 결과물을 형성하는 단계(S300)는 리액션웰(110) 내의 온도를 상승시키는 것, 및 리액션웰(110) 내의 버퍼액(BL)을 교반하는 것을 포함할 수 있다. The step of forming the reaction product (S300) may include raising the temperature in the reaction well 110 and stirring the buffer solution BL in the reaction well 110.
일 예로, 리액션웰(110) 주변에 열원(heat source)을 배치하여, 리액션웰(110) 내의 온도를 상승시킬 수 있다. 리액션웰(110) 내의 온도는 제1 및 제2 접합체들(150, 170)과 반응체(RM)가 반응할 수 있는 온도까지 상승할 수 있다.As an example, a heat source may be disposed around the reaction well 110 to increase the temperature in the reaction well 110. The temperature in the reaction well 110 may rise to a temperature at which the first and second conjugates 150 and 170 and the reactant RM can react.
리액션웰(110) 내의 버퍼액(BL)을 교반하는 것은, 제1 자석(120)을 회전시키는 것을 포함할 수 있다. 제1 자석(120)은 별도의 외력에 의해 회전할 수 있다. 예를 들면, 제1 자석(120)에 회전 모터를 연결하여 제1 자석(120)을 회전시킬 수 있다. 제1 자석(120)의 회전에 따라, 제2 자석(130)이 회전할 수 있다. 제1 자석(120)의 회전에 의한 제1 자석(120) 주변 자기장의 변화에 따라, 제2 자석(130)이 회전할 수 있다. 제2 자석(130)이 회전하면, 원심력에 의해 제3 자석들(140)이 제2 자석(130)에서 떨어질 수 있다. 제2 자석(130)의 회전에 의해, 리액션웰(110) 내의 버퍼액(BL)이 교반될 수 있다. Stirring the buffer solution BL in the reaction well 110 may include rotating the first magnet 120. The first magnet 120 may rotate by a separate external force. For example, the first magnet 120 may be rotated by connecting a rotation motor to the first magnet 120. As the first magnet 120 rotates, the second magnet 130 may rotate. The second magnet 130 may rotate according to a change in the magnetic field around the first magnet 120 due to the rotation of the first magnet 120. When the second magnet 130 rotates, the third magnets 140 may fall from the second magnet 130 by centrifugal force. By the rotation of the second magnet 130, the buffer solution BL in the reaction well 110 may be stirred.
리액션웰(110) 내의 온도가 상승하고, 리액션웰(110) 내의 버퍼액(BL)이 교반됨에 따라, 리액션웰(110) 내의 제1 및 제2 접합체들(150, 170)과 반응체(RM)가 반응할 수 있다. 다시 말하면, 제1 및 제2 접합체들(150, 170)은 반응체(RM)와 서로 연결될 수 있다. 제1 및 제2 접합체들(150, 170)과 반응체(RM)의 반응에 따라, 제3 자석(140), 제1 및 제2 접합체들(150, 170), 반응체(RM) 및 발광체(160)를 포함하는 반응 결과물(RR)이 형성될 수 있다.As the temperature in the reaction well 110 rises and the buffer solution BL in the reaction well 110 is stirred, the first and second conjugates 150 and 170 and the reactant RM in the reaction well 110 ) Can react. In other words, the first and second conjugates 150 and 170 may be connected to the reactant RM. According to the reaction between the first and second conjugates 150 and 170 and the reactant RM, the third magnet 140, the first and second conjugates 150 and 170, the reactant RM, and the light emitter A reaction product RR including 160 may be formed.
도 2 및 3d를 참조하면, 버퍼액을 리액션웰에서 제거하는 단계(S400)에서, 리액션웰(110)의 제2 개구(115)를 개방하여, 리액션웰(110) 내의 버퍼액(BL)을 리액션웰(110) 외부로 이동시킬 수 있다. 2 and 3D, in the step of removing the buffer solution from the reaction well (S400), the second opening 115 of the reaction well 110 is opened to allow the buffer solution BL in the reaction well 110 to be removed. It can be moved to the outside of the reaction well 110.
제2 자석(130)의 회전이 멈추면, 반응 결과물들(RR)의 제3 자석들(140)은 제2 자석(130)에 붙을 수 있다. 버퍼액(BL)이 리액션웰(110) 외부로 이동할 때, 제3 자석들(140)이 제2 자석(130)에 붙음에 따라, 반응 결과물들(RR)은 버퍼액(BL)과 함께 리액션웰(110) 외부로 이동하지 않을 수 있다. 다시 말하면, 반응 결과물들(RR)은 리액션웰(110) 내에 남아 있을 수 있다. 반응 결과물들(RR)을 제외한 나머지 물질들(예를 들면, 제3 자석(140)과 연결되지 못한 발광체(160) 및 제2 접합체(170))은 버퍼액(BL)과 함께 리액션웰(110) 외부로 이동할 수 있다. 다시 말하면, 상기 나머지 물질들이 리액션웰(110)에서 제거될 수 있다. When the rotation of the second magnet 130 is stopped, the third magnets 140 of the reaction products RR may be attached to the second magnet 130. When the buffer solution BL moves outside the reaction well 110, as the third magnets 140 are attached to the second magnet 130, the reaction products RR react together with the buffer solution BL. It may not move outside the well 110. In other words, the reaction products RR may remain in the reaction well 110. Materials other than the reaction products RR (for example, the light-emitting body 160 and the second conjugate 170 that are not connected to the third magnet 140) are formed with the buffer solution BL and the reaction well 110 ) Can be moved outside. In other words, the remaining materials may be removed from the reaction well 110.
이어서, 세정 단계(S500)를 진행할 수 있다. 세정 단계(S500)는, 도 3b에서 설명한 것과 유사하게 리액션웰(110) 내에 버퍼액(BL)을 채우는 것, 도 3c에서 설명한 것과 유사하게 리액션웰(110) 내의 버퍼액(BL)을 교반하는 것, 도 3d에서 설명한 것과 유사하게 리액션웰(110) 내의 버퍼액(BL)을 제거하는 것을 포함할 수 있다.Subsequently, the cleaning step S500 may be performed. The cleaning step (S500) is to fill the buffer solution BL in the reaction well 110 similar to that described in FIG. 3B, and agitate the buffer solution BL in the reaction well 110 similar to that described in FIG. 3C. It may include removing the buffer solution BL in the reaction well 110, similar to that described with reference to FIG. 3D.
상기 세정 단계(S500)에 의해, 반응 결과물(RR)을 제외한 나머지 물질들(예를 들면, 제3 자석(140)과 연결되지 못한 발광체(160) 및 제2 접합체(170))이 리액션웰(110) 내에서 제거될 수 있다. 이에 따라, 반응 결과물들(RR)에 대한 계측이 상대적으로 정확하게 이루어질 수 있다.By the cleaning step (S500), the remaining materials (for example, the luminous body 160 and the second assembly 170 that are not connected to the third magnet 140) other than the reaction product RR are removed from the reaction well ( 110) can be removed. Accordingly, measurement of the reaction products RR can be made relatively accurately.
도 2 및 3e를 참조하면, 계측 단계(S600)에서, 반응 결과물(RR)을 계측할 수 있다. 반응 결과물(RR)을 계측하는 것은, 리액션웰(110) 내의 발광체(160)에 의한 광을 계측하는 것을 포함할 수 있다. 일 예로, 발광체(160)는 형광체일 수 있다. 다른 예로, 발광체(160)는 자체 발광체일 수 있다.2 and 3E, in the measurement step S600, the reaction result RR may be measured. Measuring the reaction result RR may include measuring the light by the luminous body 160 in the reaction well 110. For example, the light-emitting body 160 may be a phosphor. As another example, the light emitter 160 may be a self light emitter.
도 3b에서 설명한 것과 유사하게 리액션웰(110) 내에 버퍼액(BL)을 채우고, 도 3c에서 설명한 것과 유사하게 리액션웰(110) 내의 버퍼액(BL)을 교반할 수 있다. 버퍼액(BL)을 교반하여, 반응 결과물(RR)의 발광체(160)를 버퍼액(BL) 내에 균일하게 분포시킨 후, 계측부(200)를 이용하여 광을 획득할 수 있다. 예를 들면, 계측부(200)에서 리액션웰(110) 내로 입사광(L1)을 조사할 수 있고, 리액션웰(110) 내에서 방출되는 방출광(L2)을 계측부(200)에서 획득할 수 있다.Similar to the one described in FIG. 3B, the buffer solution BL may be filled in the reaction well 110, and the buffer solution BL in the reaction well 110 may be stirred similarly to the one described in FIG. 3C. After stirring the buffer solution BL to uniformly distribute the light-emitting body 160 of the reaction product RR in the buffer solution BL, light may be obtained using the measurement unit 200. For example, the measurement unit 200 may irradiate the incident light L1 into the reaction well 110, and the emission light L2 emitted from the reaction well 110 may be obtained from the measurement unit 200.
획득된 광을 분석하여, 시료(SA)가 특정 반응체(RM)를 가지고 있는지 진단할 수 있다. 버퍼액을 리액션웰에서 제거하는 단계(S400) 및 세정 단계(S500)에 의해, 발광체(160)는 제3 자석(140)과 연결되어야 리액션웰(110) 내에 남아 있을 수 있으므로, 시료(SA)가 제1 및 제2 접합체들(150, 170)과 반응하는 반응체(RM)를 가지고 있어야만 발광체(160)가 리액션웰(110) 내에 남아 있을 수 있고, 발광체(160)에서 방사되는 광을 계측부(200)로 획득할 수 있다.By analyzing the acquired light, it can be diagnosed whether the sample SA has a specific reactant RM. By removing the buffer solution from the reaction well (S400) and cleaning (S500), the luminous body 160 must be connected to the third magnet 140 to remain in the reaction well 110, so that the sample SA The luminous body 160 can remain in the reaction well 110 only when the luminous body 160 has a reactant RM that reacts with the first and second conjugates 150 and 170, and the light emitted from the luminous body 160 is measured. Can be obtained with (200).
이상, 첨부된 도면을 참조하여 본 발명의 실시예를 설명하였지만, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자는 본 발명이 그 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 실시될 수 있다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예에는 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다.In the above, embodiments of the present invention have been described with reference to the accompanying drawings, but those of ordinary skill in the art to which the present invention pertains can be implemented in other specific forms without changing the technical spirit or essential features. You can understand that there is. Therefore, it should be understood that the embodiments described above are illustrative in all respects and not limiting.

Claims (16)

  1. 반응체를 포함하는 시료를 리액션웰 내에 투입하는 단계;Introducing a sample including a reactant into a reaction well;
    상기 리액션웰 내에 버퍼액을 투입하는 단계;Injecting a buffer solution into the reaction well;
    상기 리액션웰 내의 접합체들과 상기 반응체가 반응하여, 반응 결과물을 형성하는 단계;Forming a reaction product by reacting the conjugates in the reaction well and the reactant;
    상기 리액션웰 내에서 상기 버퍼액을 제거하는 단계; 및Removing the buffer solution in the reaction well; And
    상기 반응 결과물을 계측하는 단계를 포함하는 진단 장치의 구동 방법. A method of driving a diagnostic device comprising the step of measuring the reaction result.
  2. 제1 항에 있어서,The method of claim 1,
    상기 반응 결과물을 형성하는 단계는,The step of forming the reaction product,
    상기 리액션웰 내의 제2 자석이 회전하는 것을 포함하는 진단 장치의 구동 방법.A method of driving a diagnostic device comprising rotating a second magnet in the reaction well.
  3. 제2 항에 있어서,The method of claim 2,
    상기 제2 자석이 회전하는 것은,The rotation of the second magnet,
    상기 리액션웰 외부의 제1 자석이 회전하여 상기 제2 자석이 회전하는 것을 포함하는 진단 장치의 구동 방법.A driving method of a diagnostic device comprising rotating the second magnet by rotating the first magnet outside the reaction well.
  4. 제2 항에 있어서,The method of claim 2,
    상기 제2 자석이 회전하는 것은,The rotation of the second magnet,
    상기 제2 자석이 회전하여 상기 리액션웰 내의 제3 자석이 상기 제2 자석과 떨어지는 것을 포함하는 진단 장치의 구동 방법. And a third magnet in the reaction well separated from the second magnet by rotating the second magnet.
  5. 제1 항에 있어서,The method of claim 1,
    상기 반응 결과물을 형성하는 단계는,The step of forming the reaction product,
    제3 자석과 연결된 제1 접합체 및 발광체와 연결된 제2 접합체가 상기 반응체와 반응하는 것을 포함하는 진단 장치의 구동 방법. A driving method of a diagnostic device, comprising reacting a first conjugate connected to a third magnet and a second conjugate connected to a light emitter with the reactant.
  6. 제5 항에 있어서,The method of claim 5,
    상기 리액션웰 내에서 상기 버퍼액을 제거하는 단계는,The step of removing the buffer solution in the reaction well,
    상기 제3 자석을 상기 리액션웰 내의 제2 자석에 붙이는 것, 및 상기 반응 결과물을 상기 버퍼액과 함께 이동시키지 않는 것을 포함하는 진단 장치의 구동 방법.Attaching the third magnet to the second magnet in the reaction well, and not moving the reaction product together with the buffer solution.
  7. 제6 항에 있어서,The method of claim 6,
    상기 리액션웰 내에서 상기 버퍼액을 제거하는 단계는,The step of removing the buffer solution in the reaction well,
    상기 버퍼액과 함께 상기 제3 자석과 연결되지 못한 상기 발광체 및 상기 제2 접합체를 제거하는 것을 포함하는 진단 장치의 구동 방법.And removing the light-emitting body and the second assembly that are not connected to the third magnet together with the buffer solution.
  8. 제1 항에 있어서,The method of claim 1,
    상기 반응 결과물을 계측하는 단계는,The step of measuring the reaction product,
    상기 리액션웰 내의 상기 버퍼액을 교반하여 발광체를 균일하게 분포시키는 것을 포함하는 진단 장치의 구동 방법.A method of driving a diagnostic device comprising uniformly distributing a light emitter by stirring the buffer solution in the reaction well.
  9. 내부공간을 포함하는 리액션웰;A reaction well including an internal space;
    상기 리액션웰 외의 제1 자석;A first magnet other than the reaction well;
    상기 리액션웰 내에 제공되고, 상기 리액션웰에 의해 상기 제1 자석과 이격되는 제2 자석;A second magnet provided in the reaction well and spaced apart from the first magnet by the reaction well;
    상기 리액션웰 내의 제3 자석;A third magnet in the reaction well;
    상기 제3 자석과 연결되는 제1 접합체;A first bonding body connected to the third magnet;
    상기 리액션웰 내의 발광체; 및A light emitter in the reaction well; And
    상기 발광체와 연결되는 제2 접합체를 포함하는 진단 장치.A diagnostic device comprising a second conjugate connected to the luminous body.
  10. 제9 항에 있어서,The method of claim 9,
    상기 제1 자석은 회전 가능한 진단 장치.The first magnet is rotatable diagnostic device.
  11. 제10 항에 있어서,The method of claim 10,
    상기 제2 자석은 상기 제1 자석의 회전에 따라 회전하는 진단 장치.The second magnet is a diagnostic device that rotates according to the rotation of the first magnet.
  12. 제9 항에 있어서,The method of claim 9,
    상기 제1 접합체는 반응체와 결합 가능하고,The first conjugate can be combined with a reactant,
    상기 제2 접합체는 상기 반응체와 결합 가능한 진단 장치.The second conjugate is a diagnostic device capable of being combined with the reactant.
  13. 제9 항에 있어서,The method of claim 9,
    상기 제1 자석의 최대 길이는 상기 제2 자석의 최대 길이보다 긴 진단 장치.The diagnostic device in which the maximum length of the first magnet is longer than the maximum length of the second magnet.
  14. 제9 항에 있어서,The method of claim 9,
    상기 리액션웰 내에서 방출되는 광을 계측하는 계측부를 더 포함하는 진단 장치.Diagnosis device further comprising a measurement unit for measuring the light emitted in the reaction well.
  15. 제9 항에 있어서,The method of claim 9,
    상기 리액션웰은,The reaction well,
    베이스;Base;
    상기 베이스의 상면의 가장자리에서 돌출하는 측벽; 및Sidewalls protruding from the edge of the upper surface of the base; And
    상기 측벽을 관통하는 제2 개구를 포함하는 진단 장치.A diagnostic device comprising a second opening penetrating the sidewall.
  16. 제9 항에 있어서,The method of claim 9,
    상기 제3 자석의 작용기와 상기 제1 접합체의 작용기가 접합되어 상기 제3 자석 및 상기 제1 접합체가 연결되고,A functional group of the third magnet and a functional group of the first bonding body are bonded to each other to connect the third magnet and the first bonded body,
    상기 발광체의 작용기와 상기 제2 접합체의 작용기가 접합되어 상기 발광체 및 상기 제2 접합체가 연결되는 진단 장치.A diagnostic device in which the functional group of the luminous body and the functional group of the second conjugate are joined to connect the luminous body and the second conjugate.
PCT/KR2020/005442 2019-04-25 2020-04-24 Diagnostic device and method for operating diagnostic device WO2020218877A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2019-0048743 2019-04-25
KR1020190048743A KR102188470B1 (en) 2019-04-25 2019-04-25 Driving Method of Diagnostic Apparatus
KR1020190048735A KR102182254B1 (en) 2019-04-25 2019-04-25 Diagnostic Apparatus
KR10-2019-0048735 2019-04-25

Publications (1)

Publication Number Publication Date
WO2020218877A1 true WO2020218877A1 (en) 2020-10-29

Family

ID=72941064

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2020/005442 WO2020218877A1 (en) 2019-04-25 2020-04-24 Diagnostic device and method for operating diagnostic device

Country Status (1)

Country Link
WO (1) WO2020218877A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006266836A (en) * 2005-03-23 2006-10-05 Hitachi High-Technologies Corp Sample reactor
KR20080091955A (en) * 2007-04-10 2008-10-15 이금필 Magnetic force-based bio sensor comprising magnetic particles
KR101608598B1 (en) * 2014-11-20 2016-04-04 강릉원주대학교산학협력단 Stationary liquid phase lab-on-a-chip
KR101642434B1 (en) * 2016-01-21 2016-07-25 주식회사 랩 지노믹스 Apparatus including cartridge for in-vitro diagnostic bio-material
KR20190001732A (en) * 2017-06-28 2019-01-07 한국전자통신연구원 Method and apparatus for diagnosing dementia by using specific proteins in saliva

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006266836A (en) * 2005-03-23 2006-10-05 Hitachi High-Technologies Corp Sample reactor
KR20080091955A (en) * 2007-04-10 2008-10-15 이금필 Magnetic force-based bio sensor comprising magnetic particles
KR101608598B1 (en) * 2014-11-20 2016-04-04 강릉원주대학교산학협력단 Stationary liquid phase lab-on-a-chip
KR101642434B1 (en) * 2016-01-21 2016-07-25 주식회사 랩 지노믹스 Apparatus including cartridge for in-vitro diagnostic bio-material
KR20190001732A (en) * 2017-06-28 2019-01-07 한국전자통신연구원 Method and apparatus for diagnosing dementia by using specific proteins in saliva

Similar Documents

Publication Publication Date Title
JP5804194B2 (en) Medical image processing apparatus and program
JP5892238B2 (en) Medical image processing apparatus and program
JP6557658B2 (en) Microfluidic device having an isolation enclosure and method for testing biological micro-objects thereby
JP5822054B1 (en) Image processing apparatus, pathological diagnosis support system, image processing program, and image processing method
JP4192097B2 (en) Interactive transparent individual cell biochip processor
CN104297506B (en) Modular point-of-care devices, systems, and uses thereof
US20220260525A1 (en) Systems and methods for electrophoretic separation and analysis of analytes
US20100285490A1 (en) Detection apparatus
MX2008014224A (en) Real-time detection of influenza virus.
KR102227042B1 (en) Driving Method of Diagnostic System
US11231373B2 (en) Measurement method and measurement device
CN104919323A (en) Electrophoretic bar code assay devices and methods for making and using the same
WO2020218877A1 (en) Diagnostic device and method for operating diagnostic device
WO2017175914A1 (en) Modular automatic analyzer having circular cartridge, and expandable system thereof
CN105849563A (en) Microfluidic assay devices and methods for making and using the same
US7361515B2 (en) Method and test kit for detecting analytes in a sample
KR102188470B1 (en) Driving Method of Diagnostic Apparatus
WO2018143406A1 (en) Image processing device and program
KR102182254B1 (en) Diagnostic Apparatus
Haushalter et al. Multiplex flow assays
JP6375925B2 (en) Image processing apparatus, image processing system, image processing program, and image processing method
JP6337629B2 (en) Diagnosis support information generation method, image processing apparatus, diagnosis support information generation system, and image processing program
EP3396375B1 (en) Image processing device and program
WO2019093542A1 (en) Microchip and device for quantitative analysis of antigen, and method for quantitative analysis of antigen using same
WO2018056700A1 (en) High-sensitivity rapid diagnostic method of single diagnostic chip including reaction and analysis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20795499

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20795499

Country of ref document: EP

Kind code of ref document: A1